Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Industry Valuation for the Pharmaceutical Continuous Manufacturing Sector?
The size of the pharmaceutical continuous manufacturing industry has seen robust growth recently. The industry, which would be worth $2.47 billion in 2024, is projected to grow to $2.69 billion by 2025, indicating a compound annual growth rate (CAGR) of 9.2%. The growth witnessed in the past is a result of enhancements in quality and efficiency, shorter market-entry time, reduced costs, operational efficiency, and regulatory support and guidelines. Alongside these, flexibility and scalability have also played significant roles.
In the coming years, the size of the pharmaceutical continuous manufacturing market is anticipated to expand swiftly, predicted to reach “$4.08 billion in 2029,” escalating at a compound annual growth rate (CAGR) of 10.9%. The upswing during the forecast period can be credited to factors such as the escalation in generic drug production, the manufacturing of biopharmaceuticals, producing personalized medicine, along with a focus on patient-centric methodology. The forecast period will also witness major trends like the acceptance of continuous manufacturing, assimilation of process analytical technology, the utilization of advanced automation and robotics, forming strategic collaborations and partnerships along with the rise of digitalization and connectivity.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12123&type=smp
What Forces Are Driving The Growth Of The Pharmaceutical Continuous Manufacturing Market?
The proliferation of various long-term diseases is projected to boost the advancement of the pharmaceutical continuous manufacturing market in the future. These chronic diseases, typically defined as conditions lasting for at least a year, requiring ongoing medical care and affecting daily activities, serve as a primary driver. Continuous manufacturing methods aid pharmaceutical firms in optimizing the production of medications, leading to improved efficiency and reduced expenses. Access to essential medicines is also broadened, crucial for managing chronic ailments necessitating long-term medication. For example, an April 2022 report from the National Association of Chronic Disease Directors (NACDD), a non-profit Public Health organization in the US committed to chronic disease initiatives, stated that nearly 60% of American adults have a minimum of one chronic disease. Around 40% of American adults have multiple chronic conditions (MCC), which are anticipated to cost the US economy $2 trillion every year, or $8,600 per person by 2030. As a result, the escalating occurrence of numerous chronic diseases will fuel the growth of the pharmaceutical continuous manufacturing market.
The pharmaceutical continuous manufacturing market covered in this report is segmented –
1) By Product: Integrated Continuous System, Control And Software, Semi-Continuous System
2) By Therapeutics Type: Large Molecule, Small Molecule
3) By Formulation: Solid Formation, Liquid And Semi-Solid Formation
4) By Application: Final Drug Product Manufacturing, Active Pharmaceutical Ingredient (API) Manufacturing
5) By End-Users: Pharmaceutical Companies, Contract Manufacturing Organization, Other End-Users
Subsegments:
1) By Integrated Continuous System: Continuous Mixer Systems, Continuous Granulation Systems, Continuous Tablet Press Systems, Continuous Coating Systems
2) By Control and Software: Process Analytical Technology (PAT) Tools, Manufacturing Execution Systems (MES), Control Software for Automation, Data Management and Visualization Software
3) By Semi-Continuous System: Batch-to-Continuous Transition Systems, Hybrid Systems, Semi-Continuous Granulation and Drying Systems
What Future Market Trends Are Projected For The Pharmaceutical Continuous Manufacturing Industry?
Advancements in technology are becoming an increasingly significant trend within the pharmaceutical continuous manufacturing sector. Mainstream corporations involved in the pharmaceutical continuous manufacturing industry are creating new products in order to maintain their market presence. For instance, in December 2022, The United States Pharmacopeia (USP), a nonprofit establishment based in the US that possesses both the trademark and copyright of the Pharmacopeia National Formulary (USP-NF), unveiled the USP Advanced Manufacturing Technology Lab by launching R&D analytical solutions. These analytical lab services are designed to assist pharmaceutical manufacturers in the deployment of cutting-edge manufacturing processes, like pharmaceutical continuous manufacturing (PCM), to expand their geographical presence in pharmaceutical production and bolster the resilience of the medicine supply chain. This will help outline materials and establish and certify methods to support and ensure the quality of PCM-derived medications.
Which Companies Currently Dominate The Competitive Landscape In The Pharmaceutical Continuous Manufacturing Industry?
Major companies operating in the pharmaceutical continuous manufacturing market include Pfizer Inc., Robert Bosch GmbH, Siemens AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline Plc., Eli Lilly and Company, Corning Inc., Vertex Pharmaceuticals, Lonza Group Ltd., GEA Group AG, Catalent Inc., Mettler Toledo, Patheon, Cytiva, Samsung Biologics Co.Ltd., WuXi Biologics, Syntegon Technology GmbH, Coperion GmbH, Hosokawa Micron Group, FUJIFILM Diosynth Biotechnologies, Leistritz AG, Glatt GmbH, Freund-Vector Corp., SK biotek Co. Ltd., Gericke AG, GEBRÜDER LÖDIGE MASCHINENBAU GmbH, Munson Machinery Company Inc., L.B. Bohle Maschinen und Verfahren GmbH, KORSCH AG, Chemtrix BV
Which Geographic Regions Are Driving Demand In The Pharmaceutical Continuous Manufacturing Market?
Western Europe was the largest region in the pharmaceutical continuous manufacturing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical continuous manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12123&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
